135 related articles for article (PubMed ID: 16551850)
1. Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.
Castells A; Payá A; Alenda C; Rodríguez-Moranta F; Agrelo R; Andreu M; Piñol V; Castellví-Bel S; Jover R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J; Saló J; Medina E; Naranjo A; Esteller M; Piqué JM;
Clin Cancer Res; 2006 Mar; 12(6):1686-92. PubMed ID: 16551850
[TBL] [Abstract][Full Text] [Related]
2. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.
Aaltonen L; Johns L; Järvinen H; Mecklin JP; Houlston R
Clin Cancer Res; 2007 Jan; 13(1):356-61. PubMed ID: 17200375
[TBL] [Abstract][Full Text] [Related]
3. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
[TBL] [Abstract][Full Text] [Related]
4. High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum.
Planck M; Rambech E; Möslein G; Müller W; Olsson H; Nilbert M
Cancer; 2002 May; 94(9):2502-10. PubMed ID: 12015776
[TBL] [Abstract][Full Text] [Related]
5. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
[TBL] [Abstract][Full Text] [Related]
6. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.
Plaschke J; Krüger S; Dietmaier W; Gebert J; Sutter C; Mangold E; Pagenstecher C; Holinski-Feder E; Schulmann K; Möslein G; Rüschoff J; Engel C; Evans G; Schackert HK;
Hum Mutat; 2004 Mar; 23(3):285. PubMed ID: 14974087
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer.
Peng J; Jian-qiu S; Ying-hui Z; Ai-qin L; Zi-tao W; Shi-rong L
Chin Med Sci J; 2010 Dec; 25(4):206-10. PubMed ID: 21232179
[TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
[TBL] [Abstract][Full Text] [Related]
9. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
11. Clinically important molecular features of Peruvian colorectal tumours: high prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations.
Egoavil CM; Montenegro P; Soto JL; Casanova L; Sanchez-Lihon J; Castillejo MI; Martinez-Canto A; Perez-Carbonell L; Castillejo A; Guarinos C; Barbera VM; Jover R; Paya A; Alenda C
Pathology; 2011 Apr; 43(3):228-33. PubMed ID: 21436632
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Piñol V; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Payá A; Alenda C;
Gut; 2006 Jun; 55(6):848-55. PubMed ID: 16299036
[TBL] [Abstract][Full Text] [Related]
13. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
[TBL] [Abstract][Full Text] [Related]
14. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype.
Chaves P; Cruz C; Lage P; Claro I; Cravo M; Leitão CN; Soares J
J Pathol; 2000 Aug; 191(4):355-60. PubMed ID: 10918209
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer.
Ponti G; Losi L; Pellacani G; Wannesson L; Cesinaro AM; Venesio T; Petti C; Seidenari S
Br J Dermatol; 2008 Jul; 159(1):162-8. PubMed ID: 18460031
[TBL] [Abstract][Full Text] [Related]
18. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
Pavicic W; Perkiö E; Kaur S; Peltomäki P
Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer.
Chen CH; Sheng Jiang S; Hsieh LL; Tang R; Hsiung CA; Tsai HJ; Chang IS
Clin Transl Gastroenterol; 2016 Dec; 7(12):e208. PubMed ID: 27977020
[TBL] [Abstract][Full Text] [Related]
20. TGFBR1*6A may contribute to hereditary colorectal cancer.
Bian Y; Caldes T; Wijnen J; Franken P; Vasen H; Kaklamani V; Nafa K; Peterlongo P; Ellis N; Baron JA; Burn J; Moeslein G; Morrison PJ; Chen Y; Ahsan H; Watson P; Lynch HT; de la Chapelle A; Fodde R; Pasche B
J Clin Oncol; 2005 May; 23(13):3074-8. PubMed ID: 15860866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
